QJM Advance Access originally published online on March 17, 2007
QJM 2007 100(4):249; doi:10.1093/qjmed/hcm019
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2007. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
Idiopathic thrombocytopenic purpura: preliminary results in patients aged >65 years
| The first 10% of the full text of this article appears below. |
Sir,
Idiopathic thrombocytopenic purpura (ITP) is often diagnosed in the elderly, but no specific guidelines exist for such patients.1 Recent studies report that patient age may influence both therapeutic response and treatment-associated toxicity.2 We describe the preliminary results of
Department of Internal Medicine Hôpitaux Universitaires de Strasbourg France
Department of Internal Medicine Hôpitaux Universitaires de Strasbourg France
Laboratory of Immunogenetics and Allergology Centre de Recherche Public de la Santé (CRP-Santé) Luxembourg
Departments of Onco-Hematology Hôpitaux Universitaires de Strasbourg France
email: emmanuel.andres@chru-strasbourg.fr